Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cellsRyutaro Asano, Hiroko Kawaguchi, Yasuhiro Watanabe, et al.
The FEBS Journal|November 15, 2011
Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding systemRyutaro Asano, Makoto Nakayama, Hiroko Kawaguchi, et al.
The Journal of Biological Chemistry|July 24, 2007
Highly effective recombinant format of a humanized IgG-like bispecific antibody for cancer immunotherapy with retargeting of lymphocytes to tumor cellsRyutaro Asano, Yasuhiro Watanabe, Hiroko Kawaguchi, et al.
The FEBS Journal|December 18, 2009
Application of the Fc fusion format to generate tag-free bi-specific diabodiesRyutaro Asano, Keiko Ikoma, Hiroko Kawaguchi, et al.
The Journal of Biological Chemistry|May 7, 2010
Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabodyRyutaro Asano, Keiko Ikoma, Yukiko Sone, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Clinical characteristics of vascular adverse events and significance of peripheral artery disease as a risk factor in chronic myeloid leukemia patients treated with nilotinib]Masahiko Sumi, Keijiro Sato, Nozomu Uematsu, et al.
Pharmaceutical Research|December 16, 2025
Intracerebral Distribution of Drugs with Diverse Blood-brain Barrier Transport Characteristics: In vivo Analysis using Brain Microdialysis in Cynomolgus MonkeysTakuya Fujita, Yukari Kamikozawa, Makoto Ozawa, et al.
Oncology Reports|July 12, 2011
In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibodyYasuhiro Watanabe, Ryutaro Asano, Kyoko Arai, et al.
Pageof 2